Brinzolamde API

The Brinzolamide API  is a highly specific, non-competitive, reversible carbonic anhydrase inhibitor. Carbonic anhydrase (CA) is an enzyme found in many tissues of the body including the eye. Brinzolamide is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Brinzolamide was approved as a generic medication. Lowering high pressure inside the eye helps to prevent blindness. Brinzolamide API is made available by us that is very effective and safe for use.

FAQs:

Q: How does brinzolamide API work?

A: Brinzolamide API is a carbonic anhydrase inhibitor that works by decreasing the production of aqueous humor, a fluid in the eye that contributes to IOP. This reduction in fluid production helps to lower IOP and prevent damage to the optic nerve.

Q: What is the recommended dosage of brinzolamide API?

A: The recommended dosage of brinzolamide API will vary depending on the individual and their specific medical condition. It is important to follow the instructions of your healthcare provider and the prescription label carefully.

Q: What are the side effects of brinzolamide API?

A: Common side effects of brinzolamide API include blurred vision, burning or stinging of the eye, and a bitter taste in the mouth. If you experience serious side effects such as difficulty breathing or swelling of the face, lips, tongue or throat, seek medical attention immediately.